BP control crucial to prevent overt HF

More than 7.5 million deaths per year are attributable to hypertension.

Small-dense LDL and triglycerides in atherogenic dyslipidaemia

Cardiovascular disease (CVD) and Type 2 diabetes is on the increase worldwide and clinicians need to be aware of the…

Read More
CPD POINTS: 1

Vasculitis in the heart: Late complication of COVID-19

A case report has emerged of a 31-year-old woman with heart damage almost two weeks after hospital discharge.

Diuretics for hypertension

Since diuretics are an important treatment for hypertension, they have an important role in the South African healthcare system, where…

Read More
CPD POINTS: 1

Management of CV risk factors in patients with Covid-19

The Covid-19 causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects multiple organ systems, especially the lungs and heart.…

Evolocumab and CVD: What you need to know

Low-density lipoprotein (LDL) cholesterol is a well-established and modifiable risk factor for cardiovascular disease.

Different strategies to prevent and treat VTE in stroke patients

Arrhythmias – often described as ‘hijackers’ of the heart’s rhythm and pump functions, cause the heart to either beat too…

Which dual combinations work best in Black hypertensive patients?

Since the 1980s, systolic blood pressure (SBP) has increased exponentially in Black patients and currently, the highest prevalence of hypertension…

Two-thirds of Global South hypertension sufferers missing treatment

Healthcare in low- and middle-income countries is poorly prepared for the increasing number of people with high blood pressure, with…

Use of ACEIs, ARBs in Covid-19 patients

Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major concern for clinicians treating Covid-19…

Enalapril dosing recommendations

Heart disease remains the leading cause of death worldwide. Pharmacological interventions have mitigated risk factors related to heart disease to…

Read More
CPD POINTS: 1

Controlling hypertension during the COVID-19 pandemic

How should clinicians navigate clinical uncertainty for patients who are taking angiotensinconverting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs)?

Standing desks could decrease heart disease

Sitting for more than four hours a day could increase an individual’s risk of death from any health issue –…

Quitting smoking improves heart health

Smoking is a well-known cardiovascular risk factor and smoking cessation leads to a reduced risk of cardiovascular events including mortality…

Dealing with early morning BP surges

Cardio-metabolic disorders are the most important cause of mortality and morbidity worldwide. Hypertension, obesity, diabetes, metabolic syndrome and hyperlipidaemia, cause…

Preserving renal function in diabetic patients with AF

More than 40% of atrial fibrillation (AF) patients have diabetes. Chronic kidney disease (CKD), defined as an estimated glomerular filtration…

SAHS provides clarity on new hypertension threshold

In 2017, the publication of the new American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guideline created considerable controversy.…

How to TREAT-AF

Studies show that the prevalence of AF ranges from 1% to 15% in people between the ages of 35 and…

Read More
CPD POINTS: 1

Medical Chronicle August 2019 CPDs

These are both CPDs produced for the August 2019 issue of Medical Chronicle, accredited for 3 points. This month’s CPDs…

Reducing heart failure with hypertension treatment

Worldwide the prevalence of heart failure is rising. Prognosis is poor with symptomatic heart failure with yearly mortality rate of…

« » page 1 / 3